Albion Financial Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.1K | Hold |
662
| – | – | ﹤0.01% | 215 |
|
|
2025
Q1 | $66.8K | Hold |
662
| – | – | ﹤0.01% | 230 |
|
|
2024
Q4 | $59.1K | Buy |
662
+17
| +3% | +$1.52K | ﹤0.01% | 239 |
|
|
2024
Q3 | $54.1K | Hold |
645
| – | – | ﹤0.01% | 240 |
|
|
2024
Q2 | $49.7K | Hold |
645
| – | – | ﹤0.01% | 242 |
|
|
2024
Q1 | $44.2K | Buy |
645
+110
| +21% | +$7.53K | ﹤0.01% | 231 |
|
|
2023
Q4 | $30.9K | Hold |
535
| – | – | ﹤0.01% | 251 |
|
|
2023
Q3 | $28.2K | Hold |
535
| – | – | ﹤0.01% | 243 |
|
|
2023
Q2 | $28.9K | Hold |
535
| – | – | ﹤0.01% | 250 |
|
|
2023
Q1 | $26.8K | Hold |
535
| – | – | ﹤0.01% | 238 |
|
|
2022
Q4 | $24.8K | Hold |
535
| – | – | ﹤0.01% | 242 |
|
|
2022
Q3 | $21K | Sell |
535
-61
| -10% | -$2.39K | ﹤0.01% | 254 |
|
|
2022
Q2 | $22K | Hold |
596
| – | – | ﹤0.01% | 262 |
|
|
2022
Q1 | $26K | Sell |
596
-61
| -9% | -$2.66K | ﹤0.01% | 296 |
|
|
2021
Q4 | $28K | Sell |
657
-27
| -4% | -$1.15K | ﹤0.01% | 327 |
|
|
2021
Q3 | $30K | Hold |
684
| – | – | ﹤0.01% | 293 |
|
|
2021
Q2 | $29K | Buy |
+684
| New | +$29K | ﹤0.01% | 298 |
|
|
2020
Q4 | $25K | Buy |
+684
| New | +$25K | ﹤0.01% | 296 |
|